Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| The Hershey Company | INDUSTRY |
Not provided
Not provided
Not provided
Not provided
The Hershey Company is interested in investigating the effects of various chocolate beverages on brain physiology and cognitive function. The main substances in the drinks that are known to influence the brain are caffeine and related chemicals such as theobromine. Caffeine and chemicals related to caffeine are all naturally occurring and all potentially alter brain physiology. This study will evaluate changes in brain blood flow and cognition following the consumption of drinks with various combinations of the Primary Ingredients. The study proposed here will evaluate ingredients in a 4-arm cross-over double-blind design in an attempt to understand the differential effects of these compounds in chocolate drinks.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| no caffeine & no theobromine | Placebo Comparator | Drink 1 |
|
| no caffeine & low theobromine | Experimental | Drink 2 |
|
| no caffeine & high theobromine | Experimental | Drink 3 |
|
| high caffeine & no theobromine | Experimental | Drink 4 |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| no caffeine | Dietary Supplement |
| ||
| Measure | Description | Time Frame |
|---|---|---|
| Change in Working Memory (% correct) | N-Back Task | Baseline, 1.5 hour and 3.5 hours post beverage |
| Change in Response Time (milliseconds) | Choice ResponseTime Task | Baseline, 1.5 hour and 3.5 hours post beverage |
| Change in Short Term Memory (# correct) | Hopkins Verbal Learning Task (HVLT) | Baseline, 1.5 hour and 3.5 hours post beverage |
| Change in Mood (change in Likert scale score) | Profile of Mood Status (POMS) | Baseline, 1.5 hour and 3.5 hours post beverage |
| Change in Attention (% accuracy) | Eriksen Flanker Task | Baseline, 1.5 hour and 3.5 hours post beverage |
| Change in Executive Function (# correct) | Stroop Task | Baseline, 1.5 hour and 3.5 hours post beverage |
| Measure | Description | Time Frame |
|---|---|---|
| Change in Brain Blood Flow (ml/g/min) | Non-invasive brain perfusion measured with arterial spin labeling magnetic resonance imaging | 1 hour post beverage |
| % Change in Heart Rate (beats/minute) |
| Measure | Description | Time Frame |
|---|---|---|
| % Change in Brain Connectivity (network degree) | Measures of functional brain connectivity based on resting-state functional magnetic resonance imaging. | 1 hour post beverage |
Inclusion Criteria:
Exclusion Criteria:
As determined from the medical screening session
Color blindness
Individuals who are or potentially may be cognitively or psychologically impaired, or who otherwise have a limited capacity to provide consent
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Paul J Laurient, MD, PhD | Wake Forest University Health Sciences | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Wake Forest University Health Sciences | Winston-Salem | North Carolina | 27157 | United States |
Not provided
| ID | Term |
|---|---|
| D002110 | Caffeine |
| ID | Term |
|---|---|
| D014970 | Xanthines |
| D000470 | Alkaloids |
| D006571 | Heterocyclic Compounds |
| D011688 | Purinones |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| high caffeine |
| Dietary Supplement |
|
| no theobromine | Dietary Supplement |
|
| low theobromine | Dietary Supplement |
|
| high theobromine | Dietary Supplement |
|
Pulse
| before, 1 hour, and 3 hour post beverage |
| % Change in Blood Pressure (mm Hg) | before, 1 hour, and 3 hour post beverage |
| Change in Respiration (breaths/minute) | before, 1 hour, and 3 hour post beverage |
| D011687 |
| Purines |
| D006574 | Heterocyclic Compounds, 2-Ring |
| D000072471 | Heterocyclic Compounds, Fused-Ring |